Suven Life Sciences Limited (NSE:SUVEN)

Suven Life Sciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 3, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	47,531	24,730	21,742	10,570	13,484	8,961
Market Cap Growth	44.10%	13.74%	105.69%	-21.61%	50.48%	228.97%
Enterprise Value	46,931	23,067	19,870	10,468	13,313	8,934
Last Close Price	208.63	113.67	100.00	48.50	85.42	65.10
PS Ratio	632.35	371.55	185.94	77.75	112.83	63.67
PB Ratio	43.21	22.48	8.05	2.82	14.03	8.30
P/TBV Ratio	43.29	22.52	8.06	2.82	14.06	8.31
EV/Sales Ratio	-	346.57	169.93	77.00	111.40	63.48
Debt / Equity Ratio	-	-	0.00	0.00	0.03	0.04
Asset Turnover	-	0.03	0.04	0.06	0.10	0.09
Inventory Turnover	-	1.59	2.30	27.66	9.10	0.26
Quick Ratio	-	2.62	18.01	21.03	7.13	3.42
Current Ratio	-	3.21	18.99	22.61	8.01	6.45
Return on Equity (ROE)	-	-84.60%	-32.56%	-50.17%	-119.51%	-57.41%
Return on Assets (ROA)	-	-50.94%	-24.91%	-33.21%	-66.72%	-33.54%
Return on Capital (ROIC)	-62.80%	-56.20%	-25.92%	-34.65%	-74.38%	-39.72%
Earnings Yield	-3.88%	-6.50%	-4.83%	-11.19%	-9.05%	-8.05%
FCF Yield	-	-7.74%	-5.31%	-11.25%	-10.93%	-11.42%
Dividend Yield	-	-	-	-	1.17%	-
Buyback Yield / Dilution	-0.29%	-	-22.31%	-32.29%	-5.88%	-
Total Shareholder Return	-	-	-22.31%	-32.29%	-4.71%	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.